Bayesian Capital Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$444K Buy
+5,200
New +$471K 0.35% 79
2025
Q3
– Sell
-10,600
Closed -$964K – 571
2025
Q2
$964K Buy
+10,600
New +$968K 0.15% 182
2024
Q3
– Sell
-3,780
Closed -$367K – 725
2024
Q2
$367K Buy
+3,780
New +$349K 0.04% 454
2024
Q1
– Sell
-14,796
Closed -$1.18M – 814
2023
Q4
$1.18M Buy
+14,796
New +$1.11M 0.13% 201
2023
Q3
– Sell
-47,300
Closed -$3.64M – 732
2023
Q2
$3.64M Buy
+47,300
New +$3.66M 0.39% 45
2022
Q4
– Sell
-3,200
Closed -$225K – 813
2022
Q3
$225K Sell
3,200
-23,664
-88% -$1.86M 0.05% 497
2022
Q2
$2.15M Buy
+26,864
New +$2.1M 0.4% 37
2021
Q4
– Sell
-29,900
Closed -$2.26M – 398
2021
Q3
$2.26M Sell
29,900
-10,861
-27% -$862K 0.65% 26
2021
Q2
$3.32M Buy
40,761
+22,561
+124% +$1.84M 0.87% 22
2021
Q1
$1.44M Buy
+18,200
New +$1.43M 0.33% 77
2020
Q4
– Sell
-33,200
Closed -$2.56M – 480
2020
Q3
$2.56M Sell
33,200
-15,600
-32% -$1.19M 0.63% 29
2020
Q2
$3.58M Buy
48,800
+32,600
+201% +$2.32M 0.79% 16
2020
Q1
$1.08M Buy
+16,200
New +$1.14M 0.23% 113
2016
Q4
– Sell
-6,254
Closed -$464K – 608
2016
Q3
$464K Buy
+6,254
New +$462K 0.3% 115

Other funds holding CL

Bayesian Capital Management's CL Position: Q3 2026 in Review

Bayesian Capital Management opened a new position in Colgate-Palmolive (CL) in Q3 2026: 5,200 shares worth $444K. The stake represents 0.35% of the portfolio and ranks #79 among its holdings. This is a return to the name: Bayesian Capital Management previously reported a position in CL as recently as Q2 2025.

Bayesian Capital Management first reported a position in CL in Q3 2016 and has held it in 14 quarters since. The position peaked at $3.64M in Q2 2023. 1,966 funds tracked by Wall St. Rank hold CL as of Q3 2026.

  • Bayesian Capital Management held 5,200 shares of Colgate-Palmolive worth $444K as of Q3 2026.
  • Colgate-Palmolive was a new Bayesian Capital Management position in Q3 2026.
  • Colgate-Palmolive made up 0.35% of Bayesian Capital Management's portfolio in Q3 2026, its #79 holding.
  • Bayesian Capital Management first reported a position in Colgate-Palmolive in Q3 2016 and has held it in 14 quarters since.
  • Bayesian Capital Management's Colgate-Palmolive position peaked at $3.64M in Q2 2023.
  • 1,966 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2026.

Based on Bayesian Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.